An FDA advisory panel is considering whether to recommend approval of a respiratory syncytial virus (RSV) vaccine for infants.
May 18, 2023 -- An FDA advisory panel is considering whether to recommend approval of a respiratory syncytial virus vaccine for infants.“Before the pandemic, RSV was the No. 1 cause of infant hospitalization in the United States, so this is a big deal,” Ofer Levy, MD, the director of the Precision Vaccines Program at Boston Children’s Hospital, toldLevy is a temporary voting member of the FDA advisory panel but is not involved in this vote, which the FDA is not required to follow.
The vaccine, which is made by Pfizer, would be given to pregnant women in their final trimester, with the protection being passed through the placenta to the unborn baby.
México Últimas Noticias, México Titulares
Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.
FDA panel to vote on the first RSV vaccine for infants, given to pregnant mothersAn independent advisory committee to the FDA will decide on Thursday whether to recommend an RSV vaccine for infants. If approved, the shot, which is administered to pregnant mothers, would be the first of its kind.
Leer más »
FDA panel to vote on the first RSV vaccine for infants, administered to pregnant mothersIf eventually approved, the shot, which is made by Pfizer and administered to pregnant mothers, would be the first RSV vaccine for infants in the U.S.
Leer más »
FDA panel recommends the first shot to prevent RSV in infants by vaccinating pregnant mothersBREAKING: FDA panel recommends first shot to prevent RSV in infants by vaccinating pregnant mothers. If the shot gets approved, it would be the first RSV vaccine that confers protection to babies.
Leer más »
First RSV vaccine to protect infants wins backing of FDA panelThe first vaccine to protect babies from the respiratory virus RSV is a step closer to approval, after a panel of the Food and Drug Administration's outside vaccine advisers voted to back the safety and effectiveness of a new shot developed by Pfizer.
Leer más »
Pfizer RSV Vaccine for Infants Has ‘Generally Favorable' Safety Data, FDA Staff SayThe FDA is slated to make a decision on whether to approve Pfizer’s shot in August before respiratory syncytial virus season in the fall.
Leer más »